Federal Teaching Hospital, Urology Unit, Department of Surgery.
University of Ilorin Teaching Hospital, Urology Division, Department of Surgery.
Afr Health Sci. 2023 Mar;23(1):483-491. doi: 10.4314/ahs.v23i1.50.
Surgical androgen deprivation therapy (ADT) to treat advanced prostate cancer can be achieved either by bilateral total orchidectomy (BTO) or bilateral subcapsular orchidectomy (BSCO). However, biochemical and clinical equivalence between BTO and BSCO among native Africans is undocumented.
To compare the biochemical response (testosterone and prostate specific antigen) in patients who had BTO and BSCO for advanced prostate cancer.
A randomized single- blind study of 64 consenting patients that underwent either BTO or BSCO. Pre- and post-operative PSA and testosterone assays were done serially at intervals and compared between each treatment group.
Each treatment group were similar with no statistically significant difference in terms of age (p= 0.449) or degree of tumor differentiation (p =0.714). Neither median testosterone (p= 0.515) nor the mean pre-operative PSA differ between the two groups (p = 0.482). Also, similar trends were noticed post operatively except at the 2 month when a statistically significant difference was recorded (p = 0.003).
The two techniques of orchidectomy were effective in accomplishing androgen deprivation. They produced similar biochemical (testosterone and PSA) response.
外科去势治疗(ADT)用于治疗晚期前列腺癌,可以通过双侧睾丸切除术(BTO)或双侧睾丸切除术(BSCO)实现。然而,在非洲本地人中,BTO 和 BSCO 之间的生化和临床等效性尚未有记录。
比较接受 BTO 和 BSCO 治疗的晚期前列腺癌患者的生化反应(睾酮和前列腺特异性抗原)。
对 64 名同意接受 BTO 或 BSCO 的患者进行了一项随机单盲研究。在间隔时间内对每个治疗组进行了术前和术后 PSA 和睾酮检测,并进行了比较。
每个治疗组在年龄(p=0.449)或肿瘤分化程度(p=0.714)方面没有统计学上的显著差异。两组之间的中位睾酮(p=0.515)或术前 PSA 的平均值均无差异(p=0.482)。术后也出现了类似的趋势,但在 2 个月时记录到了统计学上的显著差异(p=0.003)。
这两种睾丸切除术技术都能有效地实现雄激素剥夺。它们产生了相似的生化(睾酮和 PSA)反应。